A number of studies have shown that CHAF1A is also highly expressed in breast cancer, colon cancer, CC and other tumors, and can be used as a potential marker for judging the prognosis of tumor patients and a target for tumor treatment [44]. This evidence concerns the gene CHAF1A and neoplasm.